| 000 | 01654 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514043345.0 | ||
| 264 | 0 | _c20030102 | |
| 008 | 200301s 0 0 eng d | ||
| 022 | _a0021-9258 | ||
| 024 | 7 |
_a10.1074/jbc.M208433200 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLoo, Tip W | |
| 245 | 0 | 0 |
_aLocation of the rhodamine-binding site in the human multidrug resistance P-glycoprotein. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _cNov 2002 |
||
| 300 |
_a44332-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B _xchemistry |
| 650 | 0 | 4 |
_aAdenosine Triphosphatases _xmetabolism |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 |
_aBridged Bicyclo Compounds _xpharmacology |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCysteine _xchemistry |
| 650 | 0 | 4 |
_aDNA, Complementary _xmetabolism |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aFluorescent Dyes _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Chemical |
| 650 | 0 | 4 |
_aMultidrug Resistance-Associated Proteins _xchemistry |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aProtein Structure, Tertiary |
| 650 | 0 | 4 |
_aRhodamines _xmetabolism |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 |
_aVerapamil _xpharmacology |
| 700 | 1 | _aClarke, David M | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 277 _gno. 46 _gp. 44332-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.M208433200 _zAvailable from publisher's website |
| 999 |
_c12103800 _d12103800 |
||